Dr. Glenda Grace Callender, MD

  • Bridgeport, CT
  • Surgical oncologist
NPI1952599441PAC ID3779667373
Medicare services, 2024
151
Medicare patients, 2024
80
Part D claims, 2024
30
Publications
52
Clinical trials
1
Practice address
2800 Main St, Bridgeport, CT 06606
Practice phone
Call (203) 576-5551
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

St. Vincent's Medical Center

Hospital · Bridgeport, Connecticut

See all 5 affiliations

Find Dr. Callender's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Glenda Grace Callender is a surgical oncologist in Bridgeport, Connecticut

Dr. Callender practices at St. Vincent's Medical Center in Bridgeport, Connecticut, part of Hartford HealthCare.

Dr. Callender's NPI, 1952599441, was assigned on October 9, 2007. Dr. Callender graduated from Harvard Medical School in 2000. Dr. Callender holds Connecticut license 51630.

NPI and contact details
Medicare PAC ID
3779667373
NPI enumeration date
October 9, 2007
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(203) 576-5551
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
52
Medical school graduation
2000

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Glenda Grace Callender practices at St. Vincent's Medical Center in Bridgeport, Connecticut

Dr. Callender's primary practice is St. Vincent's Medical Center, at 2800 Main St, Bridgeport, CT 06606 in Fairfield County. The practice phone is (203) 576-5551.

Source: Dmand AI Affiliation Data

Dr. Glenda Grace Callender is affiliated with 3 sites of care and 2 medical groups

Dr. Callender's primary practice is St. Vincent's Medical Center in Bridgeport, Connecticut, part of Hartford HealthCare. Dr. Callender is also affiliated with Yale New Haven Hospital. The medical group on file is Hartford HealthCare Medical Group Specialists. Dmand AI also links Dr. Callender to 1 more group practice or clinic and 1 medical group, each named with a free account.

See all 5 affiliations for Dr. Callender

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Glenda Grace Callender's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Callender practices, 3 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
St. Vincent's Medical CenterAvailable with a free account
+2 more sites and 1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Callender practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Hartford HealthCare and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Glenda Grace Callender is one of 34 surgical oncologists in Connecticut

Surgical oncology is Dr. Callender's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Callender is licensed in Connecticut.

Specialties and state licenses

  • Surgical oncology, ConnecticutPrimaryLicense 51630 · taxonomy 2086X0206X

Surgical oncologists near Dr. Callender

Counts of surgical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Glenda Grace Callender billed Medicare for 151 services in 2024

CMS data shows 151 Medicare services from Dr. Callender across 3 procedure codes in 2024, for 80 Medicare patients. Medicare paid $39,210 for them.

Medicare services, 2024151
Medicare patients80
Paid by Medicare$39,210
Procedure codes3

Dr. Callender's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Surgery
2023: 1002024: 8515%
Office and hospital visits
2023: 892024: 6626%

Where Dr. Callender's Medicare services took place, 2024

  • In an office11979%
  • In a facility3221%

Dr. Callender compared with the Connecticut median for surgical oncologists, 2024

  • Dr. Callender
  • Connecticut median
Medicare services
151vs 9756% above
Medicare patients
80vs 757% above
Part D claims
11vs 2861% below

Medians across 30 surgical oncologists in Connecticut with Dmand AI profiles that report each measure.

Dr. Callender's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Callender

Need commercial claims for Dr. Callender?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Callender and other surgical oncologists in Connecticut.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Glenda Grace Callender treated 80 Medicare patients in 2024, average age 72

CMS counts 80 Medicare patients who saw Dr. Callender in 2024. The largest group is 65 to 74, with 41 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Callender's median patient age at 63, with 77% women.

Medicare patients, 202480
Average age72
Average risk score1.56
Also on Medicaid21%

Dr. Callender's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Callender's Medicare patients by sex, 2024

  • Women6176%
  • Men1924%

Chronic conditions among Dr. Callender's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Arthritis48%
  4. Osteoporosis36%
  5. Anxiety34%
  6. Diabetes30%
  7. Ischemic heart disease28%
  8. Cancer19%

Share of Medicare patients with each condition. A patient can have several.

Dr. Callender's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 63

Patient panel by sex, all payers

  • Women77%
  • Men21%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Glenda Grace Callender wrote 30 Medicare Part D claims in 2024

In 2024, Dr. Callender wrote 30 Medicare Part D claims for 21 patients. 97% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $110 in total drug cost. In 2023, CMS named 22 claims across 1 drug.

Part D claims, 202430
Drugs named by CMS1
Total drug cost$110
Part D patients21

Dr. Callender's Part D claims by kind of drug, 2024

  • Generic29 claims97%
  • Brand-name and other1 claims3%

Dr. Callender's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 222024: 1150%

Drugs named by CMS: 1 in 2024, 1 in 2023.

See all prescribing by Dr. Callender

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Glenda Grace Callender scored 90 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Callender for performance year 2024, reported as part of a group. Dr. Callender accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Dr. Callender's MIPS scores, performance year 2024

  • 90of 100Final score
  • 83.4of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 76of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find surgical oncologists like Dr. Callender by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Glenda Grace Callender has 52 publications on record

Dmand AI links 52 papers to Dr. Callender, published from 2010 to 2020. 2012 was the busiest year, with 9. The most frequent topics are Melanoma, Skin Neoplasms and Lymphatic Metastasis. Dr. Callender has published most often in Am Surg. Dr. Callender's most frequent co-authors are Kelly M. McMasters, MD, Michael Earl Egger, MD and Amy Riddell Quillo, MD.

Papers52
Years published2010 to 2020

Dr. Callender's papers by year, 2011 to 2020

Topics Dr. Callender writes about most

  • Melanoma
  • Skin Neoplasms
  • Lymphatic Metastasis
  • Sentinel Lymph Node Biopsy
  • Liver Neoplasms
  • Adenoma
  • Colorectal Neoplasms
  • Lymph Node Excision

Dr. Callender's most frequent co-authors

Recent publications by Dr. Callender

See all 52 publications and co-authors

See who Dr. Callender researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Callender works with, so you can find a warm path to the right surgical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Glenda Grace Callender has worked on 1 clinical trial

Dmand AI links Dr. Callender to 1 clinical trial. Conditions studied include Thyroid Cancer, Papillary and Adenocarcinoma, Papillary.

Conditions in Dr. Callender's trials

  • Thyroid Cancer, Papillary
  • Adenocarcinoma, Papillary

Recent clinical trials with Dr. Callender

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Glenda Grace Callender received $296 in industry payments from 2016 to 2025

CMS Open Payments shows 5 general payments to Dr. Callender from 4 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Corcept Therapeutics paid the most, $134.

General payments to Dr. Callender by program year, 2016 to 2025

Companies that paid Dr. Callender the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Callender

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Glenda Grace Callender graduated from Harvard Medical School

Dr. Callender graduated from Harvard Medical School in 2000.

  1. Medical schoolHarvard Medical School

Source: Dmand AI Professional Profile Data

Sources for Dr. Glenda Grace Callender's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Glenda Grace Callender

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Glenda Grace Callender's NPI number?

Dr. Glenda Grace Callender's NPI number is 1952599441. It was assigned on October 9, 2007, and it is active in the NPI Registry.

What kind of doctor is Dr. Glenda Grace Callender?

Dr. Glenda Grace Callender is a surgical oncologist in Bridgeport, Connecticut. The primary specialty in the NPI Registry is Surgical Oncology Physician (taxonomy code 2086X0206X).

Where does Dr. Glenda Grace Callender practice?

Dr. Callender practices at 2800 Main St, Bridgeport, CT 06606. Dr. Callender's primary practice is St. Vincent's Medical Center in Bridgeport, Connecticut, part of Hartford HealthCare. Dmand AI also links Dr. Callender to 1 group practice or clinic and 1 medical group.

What is Dr. Glenda Grace Callender's office phone number?

The practice phone on file for Dr. Callender is (203) 576-5551.

What is Dr. Glenda Grace Callender's medical license number?

Dr. Callender holds Connecticut license 51630.

Which hospitals is Dr. Glenda Grace Callender affiliated with?

Dr. Callender practices at St. Vincent's Medical Center in Bridgeport, Connecticut. Dr. Callender is also affiliated with Yale New Haven Hospital.

What medical group is Dr. Glenda Grace Callender part of?

Dr. Callender is linked to Hartford HealthCare Medical Group Specialists. Dmand AI links Dr. Callender to 1 more medical group.

Does Dr. Glenda Grace Callender accept Medicare?

Yes. CMS data shows Dr. Callender billed Medicare for 151 services in 2024, and Dr. Callender accepts Medicare assignment.

What is Dr. Glenda Grace Callender's MIPS score?

Dr. Callender's MIPS final score for performance year 2024 is 90 out of 100, reported as part of a group.

How many Medicare patients does Dr. Glenda Grace Callender see?

CMS counts 80 Medicare patients who saw Dr. Callender in 2024, with an average age of 72.

Show 7 more questionsShow fewer questions

What services does Dr. Glenda Grace Callender bill to Medicare?

In 2024, Dr. Callender's most billed Medicare services were office visit, new patient (99204), surgery: lungs and airway (31575) and surgery: endocrine glands (60500).

Where did Dr. Glenda Grace Callender go to medical school?

Dr. Callender graduated from Harvard Medical School in 2000.

What drugs does Dr. Glenda Grace Callender prescribe most?

In 2024 Medicare Part D data, Dr. Callender's most prescribed drugs by claims were Calcitriol.

Has Dr. Glenda Grace Callender received payments from drug or device companies?

CMS Open Payments shows $296 in general payments to Dr. Callender from 4 companies from 2016 to 2025. The largest total came from Corcept Therapeutics.

How long has Dr. Glenda Grace Callender been practicing?

Dr. Callender graduated from medical school in 2000, 26 years ago.

Does Dr. Glenda Grace Callender do research?

Dmand AI links 52 publications to Dr. Callender, published from 2010 to 2020. Dr. Callender has worked on 1 clinical trial.

Who does Dr. Glenda Grace Callender publish with?

Dr. Callender's most frequent co-authors are Kelly M. McMasters, MD (25 shared papers), Michael Earl Egger, MD (12 shared papers) and Amy Riddell Quillo, MD (12 shared papers).

Selling to surgical oncology practices?

See surgical oncologists in Connecticut by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)